CARDURA- doxazosin mesylate tablet
Roerig
----------
This Patient Information has been approved by the U.S. Food and Drug Administration | Revised: 12/2020 | |||
PATIENT INFORMATION CARDURA®(kar-DUR-a) (doxazosin tablets) | ||||
What is CARDURA? | ||||
CARDURA is a prescription medicine that contains doxazosin mesylate and is called an "alpha-blocker". CARDURA is used to treat:
| ||||
It is not known if CARDURA is safe and effective in children. | ||||
Who should not take CARDURA? | ||||
Do not take CARDURA if you:
| ||||
What should I tell my healthcare provider before taking CARDURA? | ||||
Before taking CARDURA, tell your healthcare provider about all of your medical conditions, including if you:
| ||||
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. CARDURA may affect the way other medicines work, and other medicines may affect the way CARDURA works causing side effects. | ||||
Especially tell your healthcare provider if you take:
| ||||
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | ||||
How should I take CARDURA?
| ||||
Do not drive or perform any hazardous task until at least 24 hours after you have taken CARDURA if you are taking:
| ||||
What are the possible side effects of CARDURA? | ||||
CARDURA may cause serious side effects, including:
| ||||
The most common side effects of CARDURA are: | ||||
|
| |||
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of CARDURA. For more information, ask your healthcare provider or pharmacist. | ||||
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | ||||
General information about the safe and effective use of CARDURA. | ||||
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use CARDURA for a condition for which it was not prescribed. Do not give CARDURA to other people, even if they have the same symptoms you have. It may harm them. | ||||
This Patient Information leaflet summarizes the most important information about CARDURA. For more information, ask your healthcare provider. You can ask your healthcare provider or pharmacist for information that is written for healthcare professionals. | ||||
What are the ingredients in CARDURA? The size, shape and appearance of the tablet that you receive may vary, all the tablets have the same active ingredient, and this will not affect the way that the medicine works. You can identify the tablet that you have from the following information. | ||||
Strength | Either | Or | ||
1 mg Tablet | White, round tablet marked "CN1" on one side and "Pfizer" on the other side. | White, capsule shaped tablet marked "Cardura" on one side, scored and marked "1 mg" on the other side. | ||
2 mg Tablet | White, capsule shaped tablet with break score and marked "CN2" on one side and "Pfizer" on the other side. | Yellow, capsule shaped tablet marked "Cardura" on one side, scored and marked "2 mg" on the other side. | ||
4 mg Tablet | White, diamond shaped tablet with break score and marked "CN4" on one side and "Pfizer" on the other side. | Orange, capsule shaped tablet marked "Cardura" on one side, scored and marked "4 mg" on the other side. | ||
8 mg Tablet | White, capsule shaped tablet with break score and marked "CN8" on one side and "Pfizer" on the other side. | Green, capsule shaped tablet marked "Cardura" on one side, scored and marked "8 mg" on the other side. | ||
Active ingredient: doxazosin | ||||
Inactive ingredients: microcrystalline cellulose, lactose, sodium starch glycolate, magnesium stearate and sodium lauryl sulfate. The 2 mg yellow tablet contains D & C yellow 10 and FD & C yellow 6; the 4 mg orange tablet contains FD & C yellow 6; the 8 mg green tablet contains FD & C blue 2 and D & C yellow 10. | ||||
LAB-0070-6.0 | ||||
For more information, go to www.Pfizer.com or call 1-800-438-1985. |